OCD Trial, Recruiting NCT07224126 Sponsor: HabitAware Inc. Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07224126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older and have been diagnosed with trichotillomania (a hair-pulling condition, also known as TTM)
  • English is your primary language
  • You are currently not receiving any medication or therapy aimed at treating your TTM symptoms, OR you have completed a 6-week course of such treatment with no change in how often, how severe, or what dose you received
  • You have reliable and consistent access to the internet and/or a mobile device that allows you to join a virtual video meeting for up to 90 minutes
  • You own or have access to a mobile phone that runs on Apple's iOS operating system (such as an iPhone)
  • You have someone in your life who can be contacted in case of an emergency
  • You are willing to allow the Kent State research team to share your home address and phone number(s) with a company called HabitAware, Inc., so they can send you a device and help you set it up

Who may not be able to join:

  • You are currently having thoughts of harming yourself or others, or have a plan to do so
  • You have been diagnosed with another mental health condition that might make it difficult to fully use the app, such as a psychotic disorder or major depressive disorder (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (330) 672-2200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
HabitAware Inc.
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
9 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Trichotillomania Symptom Severity (NIMH-TSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov